Zobrazeno 1 - 10
of 713
pro vyhledávání: '"James, Sun"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael J. Carr, James Sun, William A. Adams, Michelle M. Dugan, Syeda M. H. Naqvi, Youngchul Kim, Jane L. Messina, Ricardo J. Gonzalez, Jonathan S. Zager, John E. Mullinax
Publikováno v:
Cancer Control, Vol 30 (2023)
Background and Objectives Primary cutaneous leiomyosarcoma (cLMS), a rare, typically intradermal tumor, has previously been reported to exhibit an indolent course of disease with zero-to-low risk of local recurrence or distant metastasis. This study
Externí odkaz:
https://doaj.org/article/93775b12258842a69b36239e6c205c1c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
James Sun, Xiaojun Zhong, Junjie Ma, Weihong Sun, Hyo S. Han, Hatem H. Soliman, Loretta S. Loftus, Ricardo L. B. Costa, Avan J. Armaghani, Aixa E. Soyano‐Muller, Brian J. Czerniecki, M. Catherine Lee, John V. Kiluk, Nazanin Khakpour, Susan J. Hoover, Christine Laronga, Hung T. Khong
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7665-7672 (2021)
Abstract Background Combination CDK4/6 inhibitor and endocrine therapy has been shown to significantly improve progression‐free survival (PFS) in patients with hormone receptor (HR)‐positive, HER2‐negative metastatic breast cancer (mBC). The ai
Externí odkaz:
https://doaj.org/article/a7be7c72b7844f4fa797e6ef99b9269b
Autor:
Yun Song, John F Thompson, Frances A Collichio, Tasha Hughes, John Vetto, Dale Han, Jonathan Zager, Zeynep Eroglu, Jennifer Downs, David E Gyorki, Nikhil I Khushalani, Alexander van Akkooi, Georgia Beasley, Lisa Kottschade, Hidde M Kroon, Ann Lee, Norma E Farrow, Giorgos Karakousis, Michael Lowe, Avinash Sharma, Kristy K Broman, Amanda Nijhuis, Tina J Hieken, Jeffrey M Farma, Meghan Hotz, Jeremiah Deneve, Martin Fleming, Edmund K Bartlett, Lesly Dossett, Russell S Berman, Emma Stahlie, Jane Yuet Ching Hui, Marc Moncrieff, Jenny Nobes, Kirsten Baecher, Matthew Perez, David W Ollila, Roger Olofsson Bagge, Jan Mattsson, Harvey Chai, Jyri Teras, James Sun, Michael J Carr, Ankita Tandon, Nalan Akgul Babacan, Younchul Kim, Mahrukh Naqvi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 8 (2022)
Until recently, most patients with sentinel lymph node-positive (SLN+) melanoma underwent a completion lymph node dissection (CLND), as mandated in published trials of adjuvant systemic therapies. Following multicenter selective lymphadenectomy trial
Externí odkaz:
https://doaj.org/article/5e2609c2e5e44274aabf900f1ff2c1c7
Autor:
Avani M. Kolla BPhil, Gerardo A. Vitiello MD, Erica B. Friedman MD, James Sun MD, Aishwarya Potdar MS, Hala Daou BS, Norma E. Farrow MD, Clara R. Farley MD, John T. Vetto MD, Dale Han MD, Marvi Tariq MD, Georgia M Beasley MD, Carlo M. Contreras MD, Michael Lowe MD, Jonathan S. Zager MD, Iman Osman MD, Russell S. Berman MD, Tracey N. Liebman MD, Jennifer A. Stein MD PhD, Ann Y. Lee MD
Publikováno v:
Cancer Control, Vol 28 (2021)
Background Acral lentiginous melanoma is associated with worse survival than other subtypes of melanoma. Understanding prognostic factors for survival and recurrence can help better inform follow-up care. Objectives To analyze the clinicopathologic f
Externí odkaz:
https://doaj.org/article/57f410acb38d4768a497f22089e561a6
Publikováno v:
Journal of Organizational Behavior (John Wiley & Sons, Inc.). Nov2021, Vol. 42 Issue 9, p1244-1260. 17p.
Autor:
Kristy K, Broman, Tasha M, Hughes, Brooke C, Bredbeck, James, Sun, Dennis, Kirichenko, Michael J, Carr, Avinash, Sharma, Edmund K, Bartlett, Amanda A G, Nijhuis, John F, Thompson, Tina J, Hieken, Lisa, Kottschade, Jennifer, Downs, David E, Gyorki, Emma, Stahlie, Alexander, van Akkooi, David W, Ollila, Kristin, O'shea, Yun, Song, Giorgos, Karakousis, Marc, Moncrieff, Jenny, Nobes, John, Vetto, Dale, Han, Meghan, Hotz, Jeffrey M, Farma, Jeremiah L, Deneve, Martin D, Fleming, Matthew, Perez, Kirsten, Baecher, Michael, Lowe, Roger Olofsson, Bagge, Jan, Mattsson, Ann Y, Lee, Russell S, Berman, Harvey, Chai, Hidde M, Kroon, Juri, Teras, Roland M, Teras, Norma E, Farrow, Georgia M, Beasley, Jane Yuet Ching, Hui, Lukas, Been, Schelto, Kruijff, Brandy, Sinco, Amod A, Sarnaik, Vernon K, Sondak, Jonathan S, Zager, Lesly A, Dossett
Publikováno v:
Annals of Surgery. 277(5):1106-1115
Objective: The aim of this study was to determine overall trends and center-level variation in utilization of completion lymph node dissection (CLND) and adjuvant systemic therapy for sentinel lymph node (SLN)-positive melanoma. Summary Background Da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8148e9aa82b592a8d19b23b3d4d03d60
https://doi.org/10.1097/SLA.0000000000005370
https://doi.org/10.1097/SLA.0000000000005370